CIP – The Anton Mostert Chair of Intellectual Property

  • Home
  • About
    • Background
    • Intellectual Property Law
    • Mission Statement
    • Staff / Members
      • Owen Dean
      • Charles Gielen
      • Sadulla Karjiker
      • Madelein Kleyn
      • Gretchen Jansen
      • Annette van Tonder
      • Christine Strauss
    • Terms and Conditions
    • IP Law Prize
  • Programmes
    • Overview
    • Master of Laws (LLM) (IP Law)
    • Postgraduate Diploma (IP Law)
    • Certificate Short Course (IP Law)
  • News
  • Blog
  • Events
    • IP Public Lecture
    • World IP Day
    • Other Events
  • Research
    • Research
    • Endnote Citation Tools
  • Contact

THIS EVENT IS NOW CLOSED

Please contact us for a transcript of the lecture.

The Chair of Intellectual Property Law will present its annual public lecture on 15 April 2014 with Dr Frederick Mostert, Chief Legal Counsel for the Richemont Group of companies which include Cartier, Montblanc, Alfred Dunhill and Van Cleef & Arpels. The topic of Dr Mostert’s address is “Hacking Back and Hot Pursuit to Protect IP Assets – a Scoop on the TradeKey Case”.

In an age of digital threats, Dr Mostert will discuss the potential methods to protect intellectual property rights online. From the intermediary liability of marketplaces to tracing and hacking back online counterfeiters and hackers, the lecture will focus on the legal grounds and methods for combatting digital infringement.

The significant TradeKey Case dealt with several questions including:

  • If you buy illegal goods on-line through a website are you or the website acting unconscionably and unlawfully and liable to legal sanctions?
  • What is the culpability of a website that directs potential customers to other websites that offer unlawful goods?
  • Is on-line trading a free for all that enables its players to be untouchables?
  • How do IP rights holders combat the sale of counterfeit goods on-line that threaten to destroy the very fabric of their businesses?

Learn how spirited trade mark owners surreptitiously infiltrated a carefully spun web of dishonesty and deceit and exposed unlawful trading practices on the internet by using counter-espionage measures, resulting in a notable precedent setting court victory against cyber bandits.

Attendance is free. Limited seating available. Please RSVP to annettev@sun.ac.za before 10 April 2014 to book your seat.

Date:

Tuesday 15 April 2014

Time:

18:00 for 18:30

Duration:

50 minutes (refreshments to follow)

Place:

The JC de Wet Hall

Stellenbosch University Faculty of Law

Ou Hoofgebou Room 1023

Corner of Victoria & Ryneveld Street, Stellenbosch

Attire:

Smart casual

RSVP:

Before 10 April 2014

Email: annettev@sun.ac.za

Call: 021 808 9371 (08:00-14:00)

To download the invitation click on the image below.

IP Public Lecture 2014

About the speaker: 

Dr Frederick Mostert holds the degrees BA (Law) cum laude, LLB cum laude and LLD from the University of Johannesburg and an LLM in Intellectual Property and Corporate Finance from Columbia University School of Law. He is also a solicitor of England and Wales and a Member of the New York Bar.

Dr Mostert is currently Chief Legal Counsel for the Richemont Group of companies which include Cartier, Montblanc, Alfred Dunhill and Van Cleef & Arpels.  He is also an executive director of Compagnie Financière Richemont SA since September 2010, Richemont International Limited since December 1991, Reinet Investments Manager S.A. and Reinet Fund Manager S.A. since September 2010. Prior to this he was an associate in the corporate department of Shearman & Sterling in New York and thereafter an associate in the international trade mark department of the firm Weiss Dawid Fross Zelnick & Lehrman P.C., also in New York.

He was appointed guest professor of Peking University, Beijing in 2002 and is a visiting professor at the University College, London and a fellow of the London School of Economics.

As an international IP expert, Dr Mostert has served as the president, honorary chairman and member of the board of the International Trademark Association (INTA). He is also a founding member of the Industry Advisory Commission of the World Intellectual Property Organisation (WIPO) and a member of the Panel of Experts of the WIPO  Internet Domain Name Process. He has served as a member of the Advisory Board of the European Union Observatory on Infringements of Intellectual Property Rights, under the auspices of the Office for Harmonisation of the Internal Market (OHIM).

Dr Mostert also serves on the advisory boards of the McCarthy Center for Intellectual Property & Technology Law at the University of San Francisco, The British Walpole Committee in London, The Art Science Research Laboratory in New York and the Teacher of Ten Thousand Generations Foundation in Hong Kong.

As an IP scholar, Dr Mostert has served on the Editorial Boards of several influential academic and practitioners’ journals including the Journal of Intellectual Property Law and Practice by Oxford University, the Trademark Reporter, Managing Intellectual Property and the Intellectual Property Magazine (Trademark World).

As an IP practitioner, Dr Mostert has on occasion provided service to Former President Nelson Mandela, His Majesty Juan Carlos I of Spain, Stella McCartney, Michael Douglas, Catherine Zeta-Jones, Sylvester Stallone, Luciano Pavarotti, Ernie Els, Jackie Chan and the Shaolin Monks.

Dr Mostert has authored or co-authored eight books on various topics of intellectual property law and contributed chapters to a further two titles. He is also a widely published scholar and his work has been cited by the Constitutional Court of South Africa, the Supreme Court of South Africa, the European Court of Justice, the Supreme Court of Canada, the US Federal Court, the Court of Appeal of Singapore, the Court of Appeal of England and Wales, the High Court of Justice and the Court of Justice of the European Communities, among others.

Dr Mostert has frequently been invited to speak with authority on a wide variety of intellectual property matters from across the world, and returns to Stellenbosch University after his last visit during the International Intellectual Property Conference hosted by the Anton Mostert Chair of IP Law in 2011.

Posted in Events, Publications Tagged counterfeit, frederick, lecture, mostert, public, trade mark, tradekey

The long-awaited South African draft National Policy on Intellectual Property (the draft IP Policy) which was published on 4 September 2013 (read the policy here) has recently led to an unfortunate furore in the press.

On 17 January 2014 Money MSN published a report based on a document that was leaked from the Innovative Pharmaceutical Association South Africa (IPASA), an industry lobby group comprising the local subsidiaries of innovator pharmaceutical companies. The document is a plan for a campaign prepared by U.S.-based consultancy Public Affairs Engagement,  to delay and modify the draft IP Policy (read more here).

This news report was followed quickly by passionate statements to the press from the South African Health Minister Aaron Motsoaledi who was very critical of the campaign.

IPASA has since distanced itself from the campaign, saying that the plan was reviewed and subsequently rejected by IPASA members.

This furore erupted over the question of patents, public health and access to medicine as dealt with in the draft IP Policy. In South Africa, which an alarmingly high incidence of HIV/AIDS as well as other diseases such as tuberculosis, malaria, hepatitis, cancer, diabetes and heart disease, one can understand that there is a passion to ensure that there is access to medicine, but it is important to keep a cool head and deal with this critically important question calmly.

The broader objectives of the draft Policy include: the development of a framework that should empower all strata of the citizens of South Africa, to contribute to development, to improve IP enforcement, to promote research and development, to improve national compliance with international treaties, to introduce a public health aspect perspective into national IP laws, to ensure that IP laws are appropriate to the level of development and innovation in a country, to engender confidence and attract investment, and to promote public education and awareness of IP in South Africa.

Unfortunately, the draft IP policy has not been drafted coherently, it contains unsubstantiated statements, and it also contains incorrect statements on the law.

Despite this, it would appear that the following suggestions/recommendations are made:

  • South Africa should maintain its sovereignty over the grant of patents and the validity of patents in South Africa.
  • The South African Patents Act should be amended to incorporate the flexibilities as highlighted in the Doha Declaration on TRIPS and Public Health; and in particular:
    • The provisions for compulsory licensing, and
    • The provisions for parallel importation.
  • South Africa should not enter in to bi-lateral trade agreements with countries that compromise the flexibilities afforded in terms of TRIPS.
  • Technology transfer contracts should be standardised to regulate restricted/prohibited technologies subject to export controls and maximum percentages.
  • South Africa should consider implementing substantive patent examination and make allowance for pre- and post- grant opposition of patents. Currently, South Africa has a deposit based patent system with no opposition procedure.
  • Extension of patent term because of regulatory delays is not desirable. Currently there is neither provision in the South African Patents Act for the extension of term of a patent, nor for the issue of Supplementary Protection Certificates (SPCs).
  • South Africa should develop incentive schemes for IP generation to achieve its developmental goals, particularly poverty alleviation and health. Public funding for research on health problems in South Africa must be increased.
  • Regulations/guidelines on licencing should be developed to encourage utilisation of patents in South Africa.
  • A suggestion is made for patent rights to be enforced administratively by a Patent Tribunal. Currently patent rights are enforced in the High Court in South Africa.

In particular, the draft IP Policy states that South Africa should make provisions in its laws that will facilitate the entry of generic competitors as soon as a patent has expired on a medicine. The draft IP Policy recognises that Section 69A of the SA Patents Act (introduced by an amendment in 2002) already has a Bolar-type provision for obtaining regulatory registration of a medicine in South Africa prior to the expiry of a patent, but which excludes stockpiling. It would appear that the draft IP Policy therefore suggests maintaining the status quo on the entry of generic medicines on to the South African market.

The draft IP Policy also states that South African legislation should exclude diagnostic, therapeutic and surgical methods from patentability, including new uses of known products. The South African Patents Act already excludes methods of treatment of the human or animal body by surgery or therapy or of diagnosis practised on the human or animal body from patentability. The use of the wording “including new uses of known products” has raised serious concern in the pharmaceutical sector. Given that the reference to methods of treatment is incorrect, it is unclear whether or not the IP Policy means to exclude patents directed to a known compound for use in a new method of treatment from patentability. If so, this would mean that current Section 25(7) of the Patents Act which specifically provides that a patent may be granted to a known compound for use in a new method of treatment (provided the new use is inventive) would have to be deleted. In the writer’s view, an amendment of this nature would be contrary to the TRIPS agreement including the flexibilities as highlighted in the Doha Declaration.

Interested parties were invited to submit comments on the draft Policy by 17 October 2013. Comments were submitted by individuals, academic institutions, industry groups, non-governmental organisations and law firms in South Africa. In the main, commentators agree with the broad objectives of the draft IP Policy, but many have expressed concern that the document is incoherent, contains unsubstantiated statements, and also contains incorrect statements on the law. This leads to uncertainty as to what the draft IP Policy means, what it intends to achieve, and the compliance of some of the recommendations with TRIPS.

Minister Rob Davies (the Minister of Trade and Industry whose department was responsible for drafting the document) has made assurances that South Africa will comply with its obligations under international treaties. In a news report Intellectual Property Watch quotes Minister Davies as saying “We are moving in a direction in striking a balance between innovation, affordable medicines and to modernise our IP regime”.

The Department of Trade and Industry held a workshop on the draft IP Policy with legal practitioners on 9 October 2013. A subsequent workshop with all stakeholders which was planned for 15 October 2013 was postponed, and the writer has recently been advised that the workshop has been “postponed until further notice”.

The 2014 South African general election will be held on 7 May 2014, to elect a new National Assembly as well as new provincial legislatures in each province. A concern has been raised that the IP Policy could be adopted in a hurry because of the upcoming general election. As stated before, the draft IP Policy is, unfortunately, an incoherent document which has glaring errors and finalisation in its current form will not assist in striking a balance between innovation, affordable medicines and modernisation of our IP regime. It is hoped that the postponed workshops will take place so that a full public consultative process can take place, and it is also hoped that a revised, coherent and substantively and legally correct document will be circulated for further comment from stakeholders including legal experts before it is signed.

Any amendments to the South African Patents Act are quite a way off. A draft Bill will have to be prepared and follow the correct legislative process which would include an opportunity for the public to submit comments on the Bill. The Bill will be debated in Parliament and voted on. The Bill must thereafter be assented to and signed by the President. The process for passing legislation in South Africa will typically take 3 years from the introduction to Parliament, although this can be accelerated if there is the necessary political willpower.

In conclusion, it is hoped that the draft IP Policy is revised and that a revised document is circulated for further comment from stakeholders including legal experts before it is signed. Any amendments to the South African Patents Act are quite a way off, and the public will be given an opportunity to submit comments during the legislative process.

 

David Cochrane

Spoor & Fisher

NOTE: This article first appeared in the magazine Managing Intellectual Property, and is reproduced here with permission.

 

Posted in Editorial, IPStell, Patents Tagged DNPIP, draft, health, patent, Pharmaceutical, policy, public

The erstwhile Intellectual Property Laws Amendment Bill (“IPLAB”), generally known as the “Traditional Knowledge Bill”, became an Act when it was published in the Government Gazette as having been assented to by President Jacob Zuma on 10 December 2013. This despite vociferous objection from the IP community and other informed sources. (Read more about IPLAB here, here, here and here.)

The general consensus was that the Bill was fundamentally flawed and an abominable piece of legislation. Issue was not taken with the notion that traditional knowledge requires improved protection, but the critics were adamant that the government were going about it in quite the wrong way, which put it out of kilter with international thinking on the subject and draft instruments prepared by the World Intellectual Property Organisation (WIPO), and that the Bill was just plain unworkable. The preferred (and eminently logical) approach was to provide for the desired protection in custom made and designed legislation which took special account of the particular circumstances of the works to be protected – so called “sui generis” protection.  A draft sui generis bill was privately prepared and it met with widespread approval. A variation of it was later introduced into Parliament as a private members bill by Dr Wilmot James of the Democratic Alliance. It was spurned by the government and instead its misconceived band wagon rolled on, culminating in the passing of IP Laws Amendment Act.

A good insight into the shortcomings of IPLAB and the objections that were raised against it can be obtained by perusing the range of articles about traditional knowledge on the IPStell blog here.

Seldom has a Bill been greeted by such damning condemnation by those in the know. The Government, however, went on its merry way unflinchingly and not in the slightest bit deterred by the weight of adverse informed opinion. The opposition to the Bill did, however, have a retarding effect and, having first seen the light of day in 2007 it took until the end of 2013 to complete the legislative process. During this time efforts were made to cosmetically change its ugly face but the fundamental flaws were left unaltered. Indeed, some of the changes aggravated the situation.  A seven year plague?  But, perhaps these were the good years compared to what is to come during the next seven year cycle.

What always perplexed the opponents of IPLAB was why it had been drafted and why the government was quite so determined to have it become law, come what may. There was no international pressure to come up with such legislation. WIPO was assiduously working at coming up with the solution to the question of protection of traditional knowledge and the international community, including South Africa, were pitching in and making their contribution to the process. It is simply a question of time before a universal international formula for protection of traditional works, providing for international reciprocal rights, is adopted.

What caused South  Africa to go off pop and attempt to do it its way? There was no local groundswell for new legislation. The “Lion Sleeps Tonight”/”Mbube” case had shown that works having a cultural or traditional flavour were capable of being protected by existing IP law.  In fact, it emerged during a workshop conducted by the Association of Law Societies in 2008 to discuss IPLAB that the Council of Traditional Leaders  of South Africa (CONTRALESA) were totally unaware of its existence of any steps that were being taken to protect traditional knowledge.  Its President, who had been invited to participate at the Workshop, took the DTI to task in no uncertain terms that it could draft and promote such legislation without prior consultation with the traditional leaders and their communities. They, after all, ought to be the beneficiaries and principal stakeholders in respect of such legislation. The plot had clearly been hatched within the confines of DTI and the government.

Opponents of IPAB formed the conviction that the DTI must have a double agenda in pursuing the matter in the manner it was doing. There could be no other rational reason for the government to pursue what is essentially a non-issue with such ardent fervour. Casting around for a possible true objective, the focus fell on the notion that promising traditional communities and leaders great wealth arising from the commercial exploitation of their cultural treasures would be a good way for the ruling party to ingratiate itself with them. Political support must inevitably flow from dangling such an attractive carrot in front of the traditional leaders.

Maybe this is what IPLAB is all about – getting traditional leaders and communities’ on-side in the forthcoming election. Any political party that can command the allegiance of the rural black communities in an election is in a very favourable position. The government has, of course, at the same time come up with the Traditional Courts Bill which confers enormous powers on traditional leaders. Coincidence?

The aforegoing is largely conjecture in the absence of any supporting evidence or substantiation. But, it is submitted that such evidence has now emerged. That evidence has been provided by Rob Davies, the Minister of Trade and Industries.

On 10 February, a matter of a couple of days after the formal announcement of the date of the forthcoming national election, Davies issued a press statement announcing the signing and becoming law of the IP Laws Amendment Act. The press statement extols the apparent virtues of the Act (statement available here). It says all the right things about the wonderful bounties that it is supposed to bestow.  It promises that the Act “will empower communities to commercialise and trade on IKs” (i.e Indigenous Knowledge).

If you are a traditional community and believe in Father Christmas and the Tooth Fairy, you will be exited at the prospect of a marvellous flow of money in your direction, in return for doing absolutely nothing other than signing a consent to use an age-old property. You don’t actually have to create or produce anything yourself, that was all taken care of by your forefathers. What a blessing from the ruling party! But then you probably also believe that the government will provide decent housing and jobs for all erelong.

What is particularly significant about this press statement is its timing; immediately after the announcement of the election. The actual signing of the Bill into law took place early in December and was announced amid no fanfare in the Government Gazette on 10 December 2013. Why no press statement then when the news was actual and hot? Why wait until two months later and give the impression that the event took place on 10 February 2014? At this stage a big fuss is made of the signing of the Act.

The answers to these questions are self-evident. The press statement and its subject matter is linked to the election. It is an instance of blatant electioneering for party political gain. This is consistent with the true objective of the legislation as outlined above.

It must be said that the content of the press statement is wishful thinking. It is submitted that the Act is not going to deliver the prizes that it promises. The Act is simply impracticable and is bad law. Those most likely to benefit are not traditional communities but rather the civil servants who are being installed in numerous new structures set up to administer the Act (in the optimistic expectation that the system will actually be used and will work), and the lawyers who are destined to have a field day in handling the numerous disputes and controversies to which the tortuous and incoherent language and contorted principles of the Act will certainly give rise.

If our hypothesis is correct, the government and the ruling party have sacrificed our IP laws on the altar of subjective political expediency and advantage. The country has now been saddled with an abominable piece of legislation that won’t work in practice (and thankfully will probably become a white elephant) and has damaged the very fabric of our IP laws by prostituting their basic principles.  All this in pursuit of gaining some extra votes at the national election. To make matters worse, we have also been opened up to international ridicule in the IP field by virtue of our adopting such patently absurd legislation.

The raiment of sheep’s clothing adorning IPLAB has been cast off to reveal a wolf inside. It is a political predator hunting down votes to support its cause. IP law has been the hapless victim of this predator and has been dealt a grievous injury. Nothing less than a successful challenge to the Constitutional Court can heal this wound. “Tis a consummation devoutly to be wished” (Shakespeare – Hamlet)

Fellows of the Anton Mostert Chair of Intellectual Property Law

Stellenbosch University

Faculty of Law

Posted in IPStell, Traditional Knowledge Tagged department of trade and industry, disaster, DTI, failure, fraud, IK, indigenous knowledge, mistake, rob davies, South Africa, TK, traditional knowledge

On 1 November 2013, the South African Department of Trade and Industry published the draft “Promotion and Protection of Investment Bill” (the “Draft Bill”) for comments.

The Draft Bill comes shortly after South Africa decided to unilaterally terminate its bilateral investment treaties (“BITs”) with certain European states and specifically Belgium, the Netherlands, Luxemburg, Germany, Spain and Switzerland.

The Draft Bill is intended to promote investment by modernising the current investment regime and getting investors, whether foreign or local, to achieve a balance of rights and obligations that apply to all investors when investing in South Africa.

The Government has stressed that the Draft Bill contains “more than enough clarity, transparency and certainty around the domestic investment regime” and that it provides “adequate protection to all investors, including foreign investors.”

Trade and Industry Minister Dr Rob Davies said on the Polity blog that “[the] DTI can expect opposition to certain proposed sections of the Investment Bill which are deemed not to provide sufficient protection or recourse to foreign investors aggrieved by the conduct of the South African government,” but negated this concern by stating that the provisions on expropriation and compensation were aligned to the Constitution, in which property may only be expropriated in terms of law of general application, for a public purpose, or in the public interest” and “[this] is also subject to compensation, which must be just and equitable, and in line with international best practice.”  (Read the full article here)

It is clear from the contents of the Bill, however, that the Bill does not provide the same standard of protection for foreign investors as provided under South Africa’s various BITs, nor is it subject to compensation, which is just and equitable, and in line with international best practice in all instances:

  • In the event of destruction or loss of property resulting from requisition by forces or authorities of the republic investors must be accorded restitution or appropriate compensation (s7 (3) of the Bill) and in case of expropriation, investors are no longer assured of compensation at full market value, but in line with the constitution, which says compensation must be “fair and equitable” (S8 (1) of the Bill). It must consider both market value and a range of public interest concerns, such as redress for the past.
  • Certain acts (and these are not limited, which creates uncertainty as to what the “other limitations” may be) do not amount to acts of expropriation:

a) A measure or series of measures taken by the government of the Republic that have an incidental or indirect adverse impact on the economic value of an investment;

b) A measure aimed at protecting or enhancing legitimate public welfare objectives, such as public health or safety, environmental protection or state security;

c) The issuance of compulsory licences granted in relation to intellectual property rights, or to the revocation, limitation or creation of intellectual property rights, to the extent that such issuance, revocation, limitation or creation is consistent with applicable international agreements on intellectual property; and

d) Any measure which results in the deprivation of property but where the State does not acquire ownership of such property provided that-

i. there is no permanent destruction of the economic value of the investment; or

ii. the investor’s ability to manage, use or control his or her investment in a meaningful way is not unduly impeded

The effect is that investors (both local and foreign) will not be entitled to compensation under the Bill if these exclusions apply.

  • The Bill removes the obligation on the government to enter into international arbitration in the event of a dispute. Investors can ask the Department of Trade and Industry to facilitate mediation or can approach the courts for relief. The trade and industry minister will draft further regulations on the settlement of disputes.
  • The Bill removes a provision contained in most bilateral investment treaties, namely that investors are entitled to “fair and equitable treatment”. This is commonly used to provide investors with an avenue to contest new legislation or regulation that alters, in a prejudicial way, the conditions under which investments are made.

The inclusion of S8(2) in the Bill appears to be a form of implementation of a catch all for some components of the recently published South African Draft National Policy on Intellectual Property wherein the DTI specifically addressed the introduction of compulsory licensing in the interest of public health. On the face of it S8 (2) appears to be unconstitutional.

This paper will focus specifically on Section 8 of the draft Bill insofar as far as it relates to intellectual property.

Interpretation of the Bill

Under the section “Interpretation of the Act” in section 2 of the Bill it is stated that the Act must be interpreted and applied with due regard to:

(a)  The Constitution

(b)   international law consistent with the Constitution;

(c)  customary international law consistent with the Constitution; and

(d)  any other relevant convention or international agreement to which the Republic is or becomes a party.

Protection of foreign investment is set out in Section 7 of the Act. The Bill specifically provides for compensation or restitution for loss or damage of property (including intellectual property) under certain circumstances and includes the provision that an investment may not be expropriated except in accordance with the Constitution and in terms of a law of general application for public purposes or in the public interest against equitable compensation in a timely manner (S8 (1)).

The Bill continues into S8(2) wherein certain acts (and there may be others as the list is non-limiting) do not amount to expropriation and as such no “just and equitable compensation” is due as the acts do not amount to expropriation.

This in itself firstly contradicts our national laws of patent protection and secondly is unconstitutional.

S8(2)(c) provides specifically that the “issuance of compulsory licences granted in relation to intellectual property rights, or to the revocation, limitation or creation of intellectual property rights, to the extent that such issuance, revocation, limitation or creation is consistent with applicable international agreements on intellectual property; and (d) any measure which results in the deprivation of property but where the State does not acquire ownership of such property provided that (i) there is no permanent destruction of the economic value of the investment; or (ii) the investor’s ability to manage, use or control his or her investment in a meaningful way is not unduly impeded.”

S8(2)(d) contradicts the provisions of S8(2)(c) as the “the revocation, limitation or creation of intellectual property rights,” in itself is the deprivation of property, whether the state acquires ownership or not. In addition “to the extent that such issuance, revocation, limitation or creation is consistent with applicable international agreements” renders the provisions of S8(2)(c) unclear as no international agreement on intellectual property (and we assume here the legislature intends to refer to TRIPS in particular) would support the expropriation of an intellectual property right creation, revocation, limitation of intellectual property rights by simply defining that certain acts do no not amount to expropriation or deprivation of such right” without following the appropriate legislation specifically in force to address the issuance, revocation and/or limitation of a right and most definitely not such support the entitlement of an intellectual property right owner to  “just and equitable compensation”

To place this in context it is necessary to discuss a few fundamental aspects of the South African law and the flexibilities of The Agreement on Trade Related Aspects of Intellectual Property Rights (“TRIPS”) of which we are a member and by which we are bound.

Intellectual Property rights and the Constitution of South Africa

There can be no doubt that intellectual property, being assets of a business, are property for the purposes of private law. Whether intellectual property constitutes property in terms of the Constitution of South Africa has been debated (See AJ van der Walt, “Constitutional Property Law”, 3rd Edition (2011) note 2 at 20).

Section 25 of the Constitution does not contain a definition of property. It simply specifies that for purposes of Constitutional protection, “property is not limited to land” (S24(4)(b)). Van der Walt interprets this to mean “that movable corporeal property as well as intangibles such as commercial interest and intellectual property [are] included under the protection on section 25 as a motive cause.”

As the law treats intellectual property as “property” there is no reason why the interpretation of van der Walt is not acceptable.

As such Section 25 of the South African Constitution applies. For present purposes, the relevant part of the section reads as follows:

(1) No one may be deprived of property except in terms of a law of general application, and no law may permit arbitrary deprivation of property.

(2) Property may be expropriated in terms of law of general application –

(a) for a public purpose or in the public interest; and

(b) subject to compensation, the amount of which and the time and manner of payment of which have either been agreed to by those affected or decided or approved by the court.

(3) ……………….

(4) For the purposes of this section –

(a) ….

(b) property is not limited to land.

Section 36(1) of the South African Constitution also has relevance to the present matter. It contains the following proviso:

(1) The rights in the Bill of Rights may be limited only in terms of law of general application to the extent that the limitation is reasonable and justifiable in an open and democratic society based on human dignity, equality and freedom, taking into account all relevant factors including

(a)  the nature of the rights;

(b)  the importance of the purpose of the limitation;

(c)  the nature and extent of the limitation;

(d)  the relation between the limitation and its purpose; and

(e)  less restrictive means to achieve the purpose.

In First National Bank of SA Limited t/a Wesbank v Commissioner for the South African Revenue Service; First National Bank of SA Limited t/a Wesbank v Minister of Finance 2002(4) SA 768 (CC). (FNB case), the court held in effect that deprivation of the property (section 25[1]) is a genus of which expropriation (section 25[2]) is a species. In considering whether a particular taking of property is an expropriation, the court must first apply the test laid down in section 25(1) for a deprivation of property [1]. Expropriation of property can only conceivably take place in instances where there has been a deprivation of property.

The methodology for determining a constitutional property dispute set forth in the FNB case is summarised by Dr Mikhalien Du Bois [2] in the following terms:

  • It must be determined whether the property interest in question qualifies as property for constitutional purposes.
  • It must next be determined whether there was a deprivation of property.
  • If there has been a deprivation of property, was it arbitrary and therefore in conflict with section 25(1)?
  • If there was an arbitrary deprivation, the second step is to determine whether section 36(1) may justify such a deprivation. If not, the enquiry ends here, since the limitation is unconstitutional.
  • In the event that the deprivation conflicts with section 25(1) (it is arbitrary) and cannot be justified under section 36(1),it must be determined whether the deprivation is also an expropriation.
  • If it does amount to an expropriation, the deprivation must be tested against the requirements set out, for present discussion, in section 25(2). Should these requirements be met, the expropriation is constitutional and the enquiry ends there.
  • However, if the requirements of section 25(2) are not met (and the expropriation in principle demands payment of compensation), the expropriation could still in principle be justified under section 36(1). If it may be justified, the expropriation is constitutional, but if section 36(1) cannot justify it, the expropriation is unconstitutional and invalid (Du Bois, op cit, 187).

The deprivation contemplated in section 25(1) was given a general description by the Constitutional Court in the FNB case as “any interference with the use, enjoyment or exploitation of private property involves some kind of deprivation relating to the entitlement to the property concerned.”

Depriving the owner of property of the use of that property thus constitutes deprivation for the purposes of section 25. Deprivation naturally also encompasses the total destruction of property, which would remove from the owner all the incidents of ownership of that property.

In the words of H Mostert and PJ Badenhorst in “Property and the Bill of Rights, the test for arbitrariness laid down in the FNB case can be summarised as “arbitrary” for purposes of section 25 when the “law” referred to in section 25(1) does not provide sufficient reason for the particular deprivation in question or is procedurally unfair.”

In other words, it is necessary for the law to strike a proportionate balance between the public purpose that it serves and the private property of which it deprives the owner. [3] The deprivation of the property must provide an effective means for achieving the end that is the objective of the law. If the deprivation is not likely to cause that end to be achieved, it will be arbitrary.

When it has been found that an arbitrary deprivation of property has taken place, it is necessary to determine whether the proportionality test provided for in section 36 can justify the deprivation. The question arises whether the proportionality test adds anything to the debate regarding arbitrariness in section 25(1). The view has been expressed that the criteria justifying a limitation of rights in section 36(1) have in effect been included in the demarcation of rights in section 25(1) itself. [4]

According to Mostert and Badenhorst, “proportionality refers to the justifiability and rationality of a particular imposition on property.” [5] It is submitted that in regard to property rights (as distinct from other types of right entrenched in the Bill of Rights), the arbitrariness test in section 25 and the proportionality test in section 36 amount to the same thing. It is difficult to conceive how a deprivation that does not provide an effective means for achieving the objective of the legislation (and is therefore arbitrary) can be justified or rational (and be proportional). Accordingly, once it is found that a deprivation is arbitrary, it will follow as a matter of course that it is not proportional and that it cannot therefore be excused or justified in terms of section 36.

For the purposes of section 25 it is necessary to distinguish between the concepts of ‘expropriation’ and ‘deprivation’. As previously stated, the former is seen to be a species of the genus constituted by the latter. This means that a particular infringement on the property right must in the first place constitute a deprivation and then, depending on its further characteristics, it may also constitute an expropriation. In terms of this approach, it is generally accepted that an expropriation and a deprivation are indeed conceptually continuous notions. [6] There is a spectrum commencing with deprivation at the one extremity and culminating with expropriation at the other extremity. At some point on the axis, deprivation metamorphoses into expropriation.

One of the most important criteria for determining when the metamorphosis takes place is the inferred requirement that expropriation necessarily entails the acquisition of the property by the state. In this regard, Mostert and Badenhorst state that under the common law, compulsory acquisition of property by a public authority for a public purpose is a prerequisite for expropriation. Opinions vary considerably as to whether this common law principle has survived the new constitutional dispensation, especially because no explicit mention is made of it in the constitutional provisions dealing with expropriation. In this regard, the Constitutional Court in the FNB case warned against referring to pre-constitutional judgements on expropriation when interpreting section 25 of the Constitution. It cautioned that circumspection was necessary because such judgements were not necessarily reliable when it came to interpreting the property clauses under the Interim Constitution and the 1996 Constitution. Uncertainty about the applicability of the appropriation requirement may render it difficult to decide whether a particular situation amounts to expropriation or not, especially when property is not taken by the state but is rather regulated to such an extent that basically nothing remains of the ownership entitlement. [7]

Mostert has expressed the view that the notion that for expropriation to take place, it is a prerequisite that deprivation should be accompanied by an acquisition of the benefits by the state seems erroneous in the constitutional context. [8]

The authorities deal with the concept of ‘constructive expropriation’. Mostert describes this concept as follows:

“A legislative or administrative measure, which has the effect of removing and destroying all the rights of the particular property holder (whether or not a corresponding advantage is granted to the expropriator or another party) without envisaging the payment of compensation, can generally be described as constructive expropriation. The intended effect of a specific imposition on an owner or property right holder should therefore be the main consideration; even if nothing in the particular legislative or administrative measure is meant to be an expropriation (or even obviously resembles an expropriation), the effect of the measure may still factually result in expropriation.” [9]

In Steinberg v South Peninsula Municipality, 2001(4) SA 1243 (SCA) the Supreme Court of Appeal said that there may be room for the development of the doctrine of constructive expropriation in South Africa in cases where a public body utilised its power to regulate private property excessively, but it left the question open. This issue was also raised and left open by the Constitutional Court in Reflect-All 1025 CC and others v MEC for Public Transport, Roads and Works, Gauteng Provincial Government and another. [10] The Supreme Court of Appeal likewise again left the question open in Minister of Minerals and Energy v Agri South Africa and another. [11]

It is submitted that there is room and justification for the incorporation of the doctrine of constructive expropriation in South African law, especially in connection with the deprivation of property in the form of intellectual property.

In the premises, it is eminently arguable that a deprivation of property that is so far-reaching or extreme as to effectively nullify or destroy all the attributes of property without actually passing ownership of a property to the state can constitute at least constructive expropriation, if not expropriation per se, for the purposes of section 25(2) of the Constitution.

Intellectual Property Rights

The rights for the different forms of intellectual property are defined in the national laws of each country and for members of the WTO incorporating aspects of TRIPS into national legislation.

In the case of a patent a valid right can be obtained if the invention meets the requirements of novelty, inventive step and industrial applicability (section 25 of the Patents Act).  In order to be registrable, aesthetic designs must be new and original (section 14(1) (a) of the Designs Act) and Functional designs must be new and not commonplace in the art in question (section 14(1) (b) of the Designs Act).

A patent (or design) can only be revoked if by means of application of revocation in terms of S61 (Article 31 in the Designs Act) or as a counter claim in an infringement action in terms of S65(4) (S35(5) of the Designs Act)).

With reference to the “applicable international agreements”, Article 32 of TRIPS provides that for any revocation/forfeiture of a patent an opportunity for judicial review of any decision to revoke or forfeit a patent shall be available and in Article 33 that the term of protection available shall not end before the expiration of a period of twenty years counted from the filing date.

As such, it is submitted that the revocation (or invalidation), or limiting of an intellectual property right without legal basis as such is a deprivation and/or expropriation of property and requires to be protected by the fundamental rights as set out in the Constitution of South Africa.

Compulsory licensing

Compulsory licensing is where a government, or other jurisdictional body, forces the holder of a patent, copyright, or other exclusive right to grant use to the state or others. Usually, the holder does receive some royalties, either set by law or determined through some form of arbitration.

TRIPS allows certain flexibilities with respect to compulsory licensing and in Article 31 of the TRIPS agreement it is stated that where WTO member states provide in their patent legislation for compulsory licences the following provisions must be made:

  • each case must be decided on its own merits;
  • the applicant for the compulsory licence must have made efforts to take a licence from the patentee on reasonable commercial terms;
  • the scope and duration of the compulsory licence must be limited to the purpose for which it was granted, such that it may be terminated or amended if the circumstances which led to the grant of the compulsory licence change or cease to exist; in the business unit that enjoys the compulsory licence);
  • the patentee must be paid adequate remuneration for use under the compulsory licence;
  • the decision to grant a compulsory licence and the determination of what is adequate remuneration shall be subject to judicial review;
  • where a compulsory licence is granted in order to enable a second patent to be exploited, the invention claimed in the second patent must involve an important technical advance of considerable economic significance in relation to the invention claimed in the first patent and the patentee of the first patent must be entitled (on reasonable terms) to a cross-licence in respect of the second patent.

In terms of South African law we find the provisions for compulsory licensing in S21 Act NO. 195 OF 1993 (the Designs Act of 1993) in the event of abuse of rights and in S56 of the Patents Act of 1978 as amended.

These Acts provide that in the case of abuse of rights by the right holder any person may apply to the court in the prescribed manner for the granting of a compulsory licence in respect of the registered design and/or patent.  In determining the conditions on which any licence is granted the court shall have regard to all relevant facts, including the risks to be undertaken by the licensee, the research and development undertaken by the registered proprietor or his predecessor and the terms and conditions usually stipulated in similar licence agreements in respect of registered designs/patents between persons who voluntarily enter into such agreements.

An abuse of rights is defined in the act and in essence can be summarised as follows – The patent holder is abusing his/her right when the patent holder is preventing the invention from being exploited by a third party and such exploitation:

  • is necessary to meet national market demands; and
  • is particularly dictated by public interest considerations; and
  • consumers are supplied with the product (subject of the patent) in insufficient quantity or of inadequate quality, or at excessively high prices.

S8(2)(c) of the Promotion and Protection Bill has the effect that the current Patents and Designs Act provisions with respect to compulsory licenses will be ignored, i.e. the process to follow as well as the form of application and the provision for compensation. It further has the direct effect of depriving the intellectual property owner of the constitutional right with respect to enjoyment of the unfettered right of property.

Conclusion

S8 (2) (c) needs to be carefully reworded to incorporate reference to South African intellectual property rights laws and a clear reference included as to the specific international agreements of intellectual property that the Promotion and Protection Bill intends to include. It will have to include a reasonable form of compensation that is aligned with the Constitution, national laws, international intellectual property standards and agreements. Due care will have to be taken that the county does not breach its obligations under the TRIPS Agreement.

It is submitted that Section 8 in its present form is unconstitutional.

Prof Owen Dean and Dr Madelein Kleyn

Editor’s Note: 
The Minister of Trade and Industry, Dr Rob Davies, has since responded to this article during a breakfast meeting of the South African Chamber of Commerce and Industry. Read more here and here on Polity.

[1] M du Bois, “Intellectual Property as a Constitutional Property Right: The South African Approach” (2012) 24 SA Merc LJ 177, at 187.

[2] Supra

[3] In general see the comments of Mostert and Badenhorst on the FNB case as expressed in op cit, paragraph 3FB7.1.2

[4] See De Waal, Currie and Erasmus, “The Bill of Rights Handbook”, 3rd Edition (2000) 393–394.

[5] Mostert and Badenhorst, op cit, paragraph 3FB7.1.2.

[6] Mostert and Badenhorst, op cit, paragraph 3FB7.1.1.

[7] Mostert and Badenhorst, op cit, paragraph 3FB7.1.1.

[8] H Mostert, “The Distinction between Deprivation and Expropriation and the Future of the ‘Doctrine’ of Constructive Expropriation in South Africa” 2003 SAJHR 567, at 572.

[9] Mostert, op cit, 569 (emphasis added).

[10] 2009(6) SA 391 (CC).

[11] Minister of Minerals and Energy v Agri South Africa (Centre for Applied Legal Studies as amicus curiae) 2012 3 All SA 266 (SCA).

Posted in IPStell, Patents Tagged deprivation, DNPIP, Draft National Policy, expropriation, intellectual property, investment bill, promotion, protection

The publication of the South African National Policy on intellectual property (SANIPP) in September 2013 has opened a proverbial can of worms and the Pharmaceutical industry is up in arms.

The SANIPP proposes the introduction of stronger IP rights through the introduction of, amongst others, pre-and post-grant opposition proceedings, and makes reference to the introduction of compulsory licensing provisions in the Patents Act.  Whilst the focus is on various industries, the matter of public health and the pharmaceutical industry forms a central theme of the SANIPP.

The Innovative Pharmaceutical Association of South Africa (IPASA) voiced its dismay with the SANIPP and made it clear that it is adamant to do all in its power to prevent the SANIPP from being implemented.  IPASA approached a Washington, DC-based, lobbying entity Public Affairs Engagement (PAE) which, amongst others, has as a goal “to shape public policy and opinions” (More information about PAE here).

PAE has proposed a campaign to delay the implementation of the policy. The Mail and Guardian published the campaign document in early January 2014 (available here).

Health Minister,  Aaron Motsoaledi, defined and the criticized the campaign document by saying “This document can sentence many South Africans to death,” he said. “That is no exaggeration. This is a plan for genocide.” (Read the article here).

The temperature of the debate has unfortunately risen out of all proportion and what is required is that all parties should take time for sober reflection so that it can be pursued on a rational, calm and constructive basis. The IP Chair has reviewed the proposed campaign and, although we are in agreement that the SANIPP is vague and of poor quality and that it should not be rushed into implementation without proper public consultation with the relevant IP role players and experts, this is where it stops.  The Chair has previously commented on the manifest shortcomings of the draft policy document.  Regrettably the document is so flawed in many respects that it is susceptible to a variety of interpretations and it may well be that its ambiguity and incoherence has been the cause of the present contretemps.  That said, the IP Chair does not agree with the PAE that the SANIPP is aimed at “justifying a weak IP regime that allows the government to abridge intellectual property rights that are well established in the developed world” or that the policy is aimed at scaring off foreign investment.

The broad objective of the SANIPP (as set out on p.4 of the Policy document) in general is to stimulate the economy of SA and to empower its citizens.  A strong IP system with integrity and credibility of IP rights granted under the system, and a system which complies with the principles of international instruments, such as TRIPS, will assist in achieving and realising the objectives.

The SANIPP includes proposals for stronger patents through the implementation of examination systems and incorporation of pre-and post-grant opposition proceedings.  Such a system, if viable for implementation in South Africa (a serious question mark must be raised in this respect), would result in patents granted that have passed the patentability tests of novelty, inventive step and industrial applicability.  The current law already lays down these substantive requirement and an examination system will not alter this in any respect.

It must be accepted that the reason for protecting intellectual property in a competitive environment is mostly related to financial benefit.  In the case of health care the subject matter requires substantial financial investment for research and development, inventions and exploitation and as such pharmaceutical companies would not make the required investment without assurance of intellectual property enforcement.

The patent system is designed to promote innovation and, at the same time, offer a mechanism ensuring that the fruits of that innovation are accessible to the general public. In the context of public health, the challenge for policy makers is to optimise the balance between the rights of patent holders, who provide technological innovations to improve health conditions, and the needs of the general public.

This challenge is an international one as health conditions and crises such as malaria, tuberculosis and HIV/AIDS continue throughout the world.

Through TRIPS certain flexibilities are provided for member countries which include the inclusion of provisions of compulsory licensing in patent legislation.

Compulsory licensing is not foreign to the developed world. There are some uniform regulations with regard to EU compulsory licenses where the EU considers the importance of granting these licenses in the interest of the community as a whole, such as compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems.[1]  Almost all of the members of the EU provide for compulsory licensing in their legislation.  Although the USA does not have compulsory licensing per se. the abuse or misuse of patent rights are provided for in US law through US Anti-Trust law[2].

Compulsory licensing does not affect the strength of IP, just the flexibility in invoking granted patent rights when such patent rights are abused.  Such abuses can include a patentee’s refusal to grant a license on reasonable terms, which causes prejudice. A compulsory licence can serve the public interest.  What terms are reasonable in any given situation can be assessed in the light of the conditions applicable to licensing in the relevant field.

Compulsory licensing is presently, and has been for quite some time, included in the South African patent law in S56 of the Patents Act.  The facility has, however,  just never been used. 

South Africa has in the past taken steps to deploy TRIPS flexibilities in the face of genuine AIDS “emergencies.”  In this context the Medicines and Related Substances Control Amendment Act No. 90 of 1997 was adopted.  The objective of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs, as well as price transparency.  This Act caused quite an uproar in February 1998 when the South African Pharmaceutical Manufacturers Association and forty Multinational Corporations (MNC) brought a law suit against the government of South Africa for its passage of this Act.  The law suit was dropped as a result of immense international pressure in April 2001.   The law is still intact and is available for use. This factor seems to have been overlooked by the writer of the draft policy document, the Minister of Health and IPASA.

In conclusion:

The SANIPP does not advocate weak IP protection.  The specific aspects raised in the SANIPP that can impact on the pharmaceutical industry per se are in fact already part of South African law.  Any delay of the implementation of these measures on account of the  steps set out in the PAE campaign document can only be to the disadvantage of South Africa.

The success of the implementation of the SANIPP will depend first and foremost on the policy being formulated in a coherent, systematic and lucid manner, unlike its presentation in the draft document. Once the policy has been properly stated its success will depend on the manner in which the objectives of the SANIPP are to be achieved and whether the IP system is moulded to suit the developmental objectives of the country and be aligned with and appropriate to the level of development and innovation of SA.  There is no implication that the level of IP protection should be lowered. This should not be the case. A strong IP protection system is generally viewed as a tool to enhance innovation, technology development and ultimately economic growth and this objective should be sought.  However, it is not through IP alone that these objectives can be reached.  In order to address public health and educational needs the role of other factors must be recognised, such as the availability and efficacy of health services, particularly public health services, the availability and pricing of essential foods, access to schools and educational institutions and the quality of the teaching and training.

The formulation and implementation of the IP Policy must take place through a civilized and properly orchestrated consultative process involving IP role players and experts in industry.  We are a democracy after all.  In this way destructive public confrontations can be avoided in the common good.

MM Kleyn

Fellow of the Chair of Intellectual Property Law

Stellenbosch

(Madelein is the Intellectual Property Manager of Oro Agri (SA) (Pty) Ltd and represent the Chair of IP of the University of Stellenbosch on patent related matters)

 


[1] See Regulation 816/2006 as adopted by the EC on 17 May 2006.

[2] U.S. DEP’T OF JUSTICE  & FED. TRADE COMM’N ,ANTITRUST ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS: PROMOTING INNOVATION AND COMPETITION (2007) available here. (Last visited on 15 June 2010).

Posted in IPStell, Patents Tagged DNPIP, Draft National Policy, health, intellectual property, patent, Pharmaceutical, public

On Monday this week (2 December 2013) the President of the Republic appointed several new judges to the courts of South Africa including, most notably, Maria (Mabel) Jansen SC.

It is with pleasure, and no small measure of pride, that this Chair conveys its congratulations to Judge Jansen on being elevated to the South Gauteng High Court (formerly the Johannesburg High Court) and wishes her well.

Following the retirement of Judge Louis Harms from the Supreme Court of Appeal, this Chair (and many others) lamented the lack of IP expertise on the bench in South Africa. For this reason, the candidacy and eventual appointment of Judge Jansen is celebrated as a most expeditious move which can help to fill the lacuna left by Judge Harms.

Mabel Jansen practised at the Pretoria Bar as a specialist IP counsel for in excess of thirty years. She served her “apprenticeship” in the IP field by assisting, as junior counsel  many of the  leading IP senior counsel of the day including Cedric Puckrin SC and Philip Ginsberg SC.  She gained excellent experience under their tutelage and was involved in a high proportion of the leading IP cases during that period. She was frequently briefed as a junior counsel acting alone by the leading specialist IP attorneys firms. After her elevation to senior status she continued to act in leading IP cases and gained the reputation of being one of the foremost IP counsel. As an acting judge she handed down good judgments in IP cases that she adjudicated and made a worthwhile contribution to the field. She has also contributed to the learning in IP by publishing several high quality articles in authoritative legal journals. She is undoubtedly an experienced IP expert and is well placed to make a significant judicial impact on IP law and its future development.

However, it appears that the President was not advised about the desperate need for an IP-expert judge and Judge Jansen’s credentials in that regard. As all IP practitioners know, the heart of IP litigation beats not in the South Gauteng High Court but rather in the North Gauteng High Court (Pretoria), which is home to the Companies and Intellectual Property Commission and the exclusive seat of the court of the Commissioner of Patents.

Furthermore, as the Department of Trade and Industry were at pains to point out in the Draft National Policy on Intellectual Property Law, patent law lies at the core of innovation and commercialisation of IP in South Africa. Therefore, it makes perfect sense that the only IP-expert judge should be appointed to the only court in the land with jurisdiction over patent matters, i.e. the North Gauteng High Court.

Why then would Judge Jansen be appointed to the South instead of the North? The only conceivable answer is that the President, as advised by the Minister of Justice, overlooked the fact that patent matters are referred to the NGHC only. There can be no other rational explanation..

The fact that South Africa can only call on a single specialist IP judge is a constant trial to academics and practitioners alike. The circumstance that the highest specialty in law, namely patents, should be adjudicated by non-IP savvy judges, while a skilled and experienced IP expert sits on the bench not far from there, could clearly not have been the intention of the Minister of Justice.

Hopefully, the judiciary will amend this oversight.

Office of the Anton Mostert Chair of Intellectual Property Law

UPDATE: Following the publication of this article and the widespread support expressed in the comments below and elsewhere, Jansen J has been appointed to the North Gauteng High Court.

Posted in From the Chair, Publications Tagged bench, court, IP law, Jansen, Judge 5 Comments

As of 6 December this year you will no longer see a nurturing mother feeding her happy baby a bottle of formula milk as an advertisement in any newspaper, magazine, on a website or on television. In fact, you will not see the names of any brand or logos of infant formula, follow-up formula or powdered milks, or feeding bottles, teats and feeding cups for infants being promoted anywhere. Well, you will still see the names on the products as you are standing in front of the shelf in the supermarket and wondering which product is the best option for your little angel. You will have to try and make sense of it all on your own, however, since you will not be allowed to ask your health care practitioner for advice on your options. The manufacturers of these products will also not be allowed to give you any information or advice on infant nutrition.

On 6 December 2013 regulation 7 of Regulations R991 PDF_Icon, relating to foodstuffs for infants and young children will come into operation. Still yet to enter into force, however, are regulations 2 to 6 of R991, scheduled to happen on 6 December 2014. After this date, you will no longer see any pictures on any infant and follow-up formula, infant or follow-up formula for special dietary or medical purposes; liquid milks, powdered milks, modified powdered milks, or powdered drinks marketed or otherwise represented as suitable for infants or young children; feeding bottles, teats and feeding cups with spouts, straws or teats or complementary foods (the “designated products”). No smiling faces, no flowers, no trucks, trains or cars, no shining sun. At least there may be a picture of the strawberry on the strawberry juice. And of course a picture of how you are supposed to prepare the porridge/milk/pureed broccoli.

Sounds familiar?

Where have you heard about something like this before, I hear you ask? Plain packaging for tobacco products of course, and maybe for alcoholic beverages too. You can see the clear link with baby food, can’t you?

On 6 December 2012 the South African Minister of Health, Dr Aaron Motsoaledi, published regulations in terms of s 15(1) of the Foodstuffs, Cosmetics and Disinfectants Act, 54 of 1972.  In terms of these regulations a number of restrictions are placed on the labelling, advertisement and promotion of the designated products. The final version of these regulations followed a previous draft published for public comment in March 2012 and contains somewhat less restrictive provisions than its original predecessor. The purpose of these regulations, or so it has been explained by the Department of Health, is to promote breastfeeding. At the time of the publication of the regulations in December 2012, the Department of Health’s Director for Nutrition explained that exclusive breastfeeding rates in South Africa is at an all-time low of 8%  and infant mortality rates stand at 40 per 1 000 live births.  As a result “South Africa needs to put into place a comprehensive legal framework that protects parents and health professionals from aggressive or inappropriate marketing of breast milk substitutes”.   It can therefore be assumed that regulations R991 form part of this “legal framework that protects” consumers.

Dispensing milk of human kindness

Regulation 7 of R991 prohibits promotional practices in respect of infant and follow-up formula, and other powdered milks or powdered drinks marketed or otherwise represented as suitable for infants or young children; feeding bottles, teats and feeding cups with spouts, straws or teats; or any other products that the Minister may publish by notice in the Gazette.  Despite the fact that regulation 1 provides a definition of what it means to “promote”, regulation 7(2) describes the list of prohibited practices to include, inter alia, sale devices such as rebates, benefits in kind, kickbacks or any other pecuniary advantages, special displays to promote sales, advertisements about the availability of the product at a specific retail outlet and the price of the product, tie-in sales, discounts in any form, competitions with prizes, or any other incentives and gifts. The list goes on: no “direct or indirect contact between company personnel and members of the public in furtherance of or for the purpose of promoting the business of the company with regard to the products referred to in sub-regulation 7(1)” and for purposes of these regulations “indirect contact” specifically includes internet sites hosted on behalf of a South African entity or an entity that does business in South Africa, television and radio, telephone or internet help lines and mother and baby clubs but excludes contact in regards to product quality complaints and adverse events; no distribution of any information or educational material on the nutrition or feeding of infants and young children; no promotional items such as stationery, T-shirts or other items of clothing etc that refer to the designated products; no exhibition of the brand name of a designated product when used at any event for the general public; and no advertisements anywhere. Regulation 7(3) also explicitly prohibits the sale, promotion or advertisement of the listed products, as well as that of complementary foods, through health care personnel or health establishments. An institutional pharmacy in a private health establishment may however, sell a designated product but has to refrain from promoting or advertising it.

Regulation 7(4) prohibits any manufacturer, distributor, retailer, importer or person on behalf of such, from producing or distributing any educational material on infant and young child feeding that promotes any of the identified products. Regulation 7(5) extends even further by prohibiting any of the above-mentioned persons from producing, distributing or presenting educational information relating to infant and young child nutrition.

Other strict requirements regarding the labelling and packaging of the designated products are found in regulations 2 to 6.  These include the prohibition of any graphic representation, apart from those necessary to show the correct method of preparing and using the product, and pictures of the ingredient or prepared product.  The company logo and brand name will be permitted, provided that they do not contain a picture of an infant, young child or other humanised figure.  The label of the relevant products may also not refer to, or promote or advertise any other designated product. Any incentive, enticement or invitation of any nature, which might encourage consumers to make contact with the manufacturer or distributor of a designated product which might result in the sale or the promotion of a designated product for infants or young children, is proscribed from appearing on the label or in the marketing of such a product.  Apart from other strict instructions relating to the appearance and wording of the labelling, the regulations also contain a mandatory provision that the words “[t]his product shall only be used on the advice of a health professional” shall appear on the front main panel of the label of a designated product.  This is followed by an instruction that a prominent statement printed in bold letters of at least 3mm in height stating “USE UNDER MEDICAL SUPERVISION” shall also appear on the label. Regulation 4(3)(b) prohibits the use of expressions or names that may be understood to identify the product as suitable to feed infants. Such phrases include the terms “first growth”, “first food”, “from the start” and “best start in life”. In terms of regulation 17 all non-compliant products must be removed from the market by 12 December 2015.

Super trade marks

It is apparent that in the estimation of the Department of Health trade marks are a mighty force, and a malevolent one at that. They have immense powers. They can cause people to smoke and drink and bring about cancer and alcoholism. They can even wean babies off mother’s milk. Regulation R991 amounts to a declaration of war against baby food trade marks.

Source: www.parmalat.com

Source: www.parmalat.com

Apart from the restrictions which these regulations place on the freedom of commercial speech and consumers’ rights, R991 prohibit a brand name or company logo from including a picture of an infant, young child or a humanized figure on the packaging of the designated products. This means that a company such as Gerber, producer of a number of baby food products, may not use their logo portraying the picture of a baby’s face, in South Africa. Products such as FIRST GROWTH MILK® may no longer use this name for their brand of milk in South Africa since regulation 4(3)(b) prohibits the use of expressions or names that may be understood to identify the product as suitable to feed infants.

Professor Owen Dean in his paper entitled “Deprivation of Trade Marks Through State Interference in Their Usage” and his article on this blog entitled “Brand Genocide” makes a compelling argument that the proposed ban of the use of brand logos on cigarette packaging, thus only allowing brand names or product names to be depicted in a plain manner, constitutes the deprivation of property. Section 25(1) of the Constitution provides that no one may be deprived of property except in terms of law of general application, and no law may permit arbitrary deprivation of property. Expropriation of property is allowed in terms of s 25(2) but only in terms of law of general application and only if that expropriation is for a public purpose or in the public interest; and furthermore, only if compensation has been paid, the amount of which and the time and manner of payment of which have either been agreed to by those affected or decided or approved by a court. Dean argues that deprivation of trademarks will take place if the state prevents their use and thereby destroys them. This includes any “interference with the use, enjoyment or exploitation of private property.” When registered trademarks are not used for a period of five years or longer, they become liable to cancellation on the grounds of non-use and thus can be destroyed or obliterated. This then, ultimately, leads to the deprivation of the intellectual property held by the owners of the trademarks or brand names. Legislation to this effect offends against the Constitution.

The same argument can also be made in respect of regulations R991: these provisions too deprive the owners of registered trademarks such as Parmalat of their property since they may no longer use FIRST GROWTH as one of their brands in this country. It is submitted that this arbitrary deprivation of property cannot be allowed. Should the Department of Health choose to expropriate the trade marks held by the manufacturers of infant and follow-up formula, complementary food and liquid or powdered milks marketed as suitable for infants or young children, it will have to prove that it is in the public interest to do so and compensate the owners accordingly. This will, in effect, mean that the Department of Health will have to prove that the use of pictures of children or other humanized figures, and the use of phrases such as “first food” or “good start” directly contributes to these products supplanting breastfeeding. Will they be able to show that trade marks weave their evil magic in this regard?

Conclusion

The promotion of breastfeeding is, for a variety of reasons, a vital and laudable goal to pursue. The practice of this very natural and basic method of nursing holds health benefits for both mother and child. Consequently the Minister and the Department of Health are indeed attempting to improve public health in South Africa. Nonetheless, the attempt to do so by means of regulations R991 can be criticised for a number of reasons, some of which have been explained above.

The right to freedom of speech, which includes the right to receive and impart information, cannot simply be disregarded in the name of the promotion of healthier choices. The prohibition of all forms of advertising, including the publication of the price of the list of designated products, and especially products which are used for children older than six months, is an overbroad and disproportionate method to promote breastfeeding. So too is the prohibition which is placed on the manufacturers of these products to, in fact, promote breastfeeding by prohibiting them from providing educational information relating to infant and young child nutrition.

The effect which these prohibitions will have on the consumers’ right to information regarding products which most parents will have to make use of at some point during their children’s lives is excessive and unwarranted. These products should be appropriately marketed and distributed in ways that do not interfere with breastfeeding. Not everyone can breastfeed. Not everyone may choose to breastfeed. In some instances it will even be in the best interests of a child if she is not breastfed. If consumers are provided with as much information as possible regarding the benefits of breastfeeding and if they are not misled by dishonest claims by marketers of the designated products, consumers should be trusted to make informed decisions. It is submitted that providing women with the opportunities and facilities to breastfeed, also in public and especially when she returns to employment, will be a more positive and effective way to promote breastfeeding.

A brazen disregard of the right to freedom of choice, the right to commercial speech and the right to intellectual property cannot be accepted in a democratic and free society. Finding an appropriate balance between the best interests of the child, her health and these freedoms is by no means an easy task and it is in not suggested that regulations R991 should be dismissed in its entirety either. The underlying intention of the regulations must be pursued but it must be done in such a way that the means meets the requirements set by s 36 of the Constitution. The means to the end must be reasonable and proportionate. To place extensive advertising bans on consumer products, especially ones which are not inherently harmful, is not reasonable or proportionate and philosophically in conflict with the notion of a rational public which forms the foundation of respect for freedom of expression.

Lize Mills

Senior Lecturer, Department of Private Law, Stellenbosch University

IPStell Editor:

It is worth noting that (as the eminent IPKat reports here) the European Parliament rejected plain packaging in relation to tobacco products and that two independent studies by KPMG and London Economics found that plain packaging “might not [have] the desired effect”. Read the full reports, and more, here.

Posted in Editorial, IPStell, Trade Marks Tagged baby, formula, health, milk, plain packaging, regulation

While trade mark infringement cases are not unusual, there are few decisions in which the central issue which required determination was whether the respective goods involved were so similar that it would gave rise to a likelihood of deception or confusion.  It is for this reasonthat the decision in Mettenheimer & Another v Zonquasdrif Vineyards CC & Others ([2013] ZASCA 152) deserves consideration.

Mr Mettenheimer, the first appellant, was the proprietor of the ZONQUASDRIFT trade mark, registered in class 33 in respect of alcoholic beverages, including wine.  Importantly, the trade mark registration did not cover wine grapes, which, incidentally, falls in class 31.  The second appellant owned a farm called Zonquasdrift.  The appellants were not wine makers, but were wine-grape producers, and, on a more limited scale, wine exporters under the ZONQUASDRIFT trade mark.  The wine exported under the ZONQUASDRIFT trade mark was made by Riebeek Cellars exclusively from grapes from the appellants’ farm.

The respondent was a close corporation with the registered name Zonquasdrif Vineyards CC, which conducted its farming business, growing wine grapes, on a farm situated about one kilometre from the appellants’ farm, and which it sold under its registered name, Zonquasdrif Vineyards.  It never sold or made wines.

The appellants sought, inter alia, an interdict pursuant to s 34(1)(b) of the Trade Marks Act 1993 on the basis that the respondent’s sale of wine grapes under its registered name infringed its ZONQUASDRIFT trade mark.  It is the court a quo’s dismissal of the appellants’ application for the interdict that led to the appeal.

A claim for trade mark infringement pursuant to section 34(1)(b) does not require that the impugned mark be used in relation to goods (or services) for which the trade mark has been registered.  It requires the establishment of two interdependent elements: the use of a mark identical (or similar) to the registered trade mark, and that such mark be used in relation to goods which are so similar to those for which it was registered that it gives rise to a likelihood of deception or confusion.  There is an interdependence because the less the similarity between the respective goods of the parties, the greater will be the degree of resemblance required between the marks before it can be said that there is a likelihood of deception or confusion in the use of the allegedly offending mark, and vice versa.

Given the fact that the deception or confusion must relate to the origin of the respective goods, the issue to be decided was whether there was a likelihood that the notional purchaser of either product (that is, appellants’ wine or the respondent’s wine grapes) may be confused to think that these goods had the same origin.

The two marks were held to be virtually identical.  Although the respondent’s mark contained the additional reference to ‘Vineyards,’ the ‘Zonquasdrif’ portion was the dominant feature of the mark, which would be the memorable portion to consumers.  The difference in spelling of ‘Zonquasdrif’ – the absence of the final ‘t’ in the respondent’s mark – was considered to be insignificant.  If the difference was noticed by consumers, they may have ascribed it to a misspelling of the appellants’ mark.

Whether such confusion existed, therefore, depended on whether the mark was used in relation to goods which were so similar to those for which it was registered that it gave rise to a likelihood of deception or confusion.  In determining whether there was a likelihood of confusion, the following, non-exhaustive, factors may be used to in making such determination: (a) the uses of the respective goods; (b) the users of the respective goods; (c) the physical nature of the goods; and (d) the respective trade channels through which the goods reach the market.

On application of these considerations to wine grapes and wine, the court held that the likelihood of confusion was slight.  Simply because wine is made from wine grapes did not mean that the two products were similar.  The nature of the two products was entirely different.  The one was a fruit – albeit inedible – and the other was an alcoholic beverage.  There were differences as to their uses, users and the trade channels through which they were marketed.  Wine grapes, not being suitable for consumption as fruit, were not sold to the public, and, therefore, not found in retail outlets.  Wine, on the other hand, was marketed, advertised and sold directly to the public in supermarkets, liquor stores and other retail outlets.  There were no prospects of ZONQUASDRIFT wine and Zonquasdrif grapes being marketed or sold in close proximity.

Given the differences in the two products, it was necessary to consider the notional purchasers of each good.  As wine grapes were suitable for winemaking only, they were exclusively sold to wine makers and wine co-operatives for that purpose.  These purchasers purchased grapes based on a number of factors, such as the cultivar and the specific environmental conditions (terroir), but not with reference to the trade names of wine or the names of farms.  Wineries and co-operative cellars employ specialists in the wine industry to buy their wine grapes from approved suppliers who comply with their own established quality control standards.  The court held that there was no chance that these specialist purchasers of the respondent’s wine grapes would think that those grapes were from the farm from which the appellants made their wine.

Furthermore, it held that there was no likelihood that purchasers of appellants’ ZONQUASDRIFT wine would believe that the wine originated from the same farm as the respondent’s grapes.  It could not be assumed that the notional wine purchaser would be aware of the respondent’s grapes that were sold under its trade name, as the respondent did not sell its grapes in retail outlets or advertise them to the public.  It was well known that many trade marks in the wine industry are not associated with farms at all.  Even if the notional wine purchaser knew of the farm Zonquasdrift, it would not necessarily have inferred that the farm and the trade name belong to the same proprietor.  Moreover, even if such assumption was made, there was no reason for such purchaser to infer that the ZONQUASDRIFT wine was made of grapes grown on that farm.

In relation to wine (and as understood in the wine industry) a trade mark served to guarantee the origin of the wine only, not the grapes from which the wine was made.  The origin of the grapes from which a wine is made is provided by the wine of origin designation pursuant to the Liquor Products Act 1989.

Accordingly, the appellants’ had not established a likelihood of confusion with regard to the origin of their ZONQUASDRIFT wine and the respondent’s grapes.

While the case is factually interesting, it has not established new law.  The decision does, however, assist one in assessing whether two goods may be considered to be so similar, from the consumers’ perspective, that it would gave rise to a likelihood of deception or confusion.  It emphasises the importance of not making snap judgements about whether goods are similar from a trade mark perspective, without a proper consideration of the particular facts.  Trade mark disputes tend to be fact specific, requiring an application of the relevant legal principles to the particular facts.

In this particular case, the decisive factual finding was, arguably, that there was no likelihood that purchasers of appellants’ ZONQUASDRIFT wine would believe that the wine originated from the same origin as the respondent’s grapes.  The basis for such finding appears to have been based on a possible peculiarity in the wine industry: consumers of wines do not assume that a trade-marked wine has any connection with a particular farm, or that a farm with the same (or similar) name as the wine belong to the same proprietor.  This, it is submitted, will not necessarily be the case where one product is the dominant ingredient of another product.  Thus, the effect of the judgment may be quite limited due to the specific factual situation.

Interestingly, the case suggests that the decision may have been quite different if the appellant’s goods were table grapes, rather than wine grapes.  Given the fact that table grapes tend to be sold to the public via retail outlets, consumers may be likely to assume that table grapes sold under a particular mark have the same origin as a similar trade-marked wine.

 Sadulla Karjiker

Posted in IPStell, Trade Marks Tagged trade, trade mark, trademark, trademarks, wine

Introduction

The Draft National Policy on Intellectual Property (DNPIP) of South Africa was published on 4 September 2013 for public comments. Despite the fact that the DNPIP is not conducive to a systematic and consequential analysis of it and displays an alarming lack of understanding and/or knowledge of existing South African IP law one cannot overlook the repetitive element of requirement for “stronger patents” which the DNPIP states will be achieved through implementation of a search and examination system as well as pre- and post-grant opposition proceedings.

There are different views among the IP experts and practitioners as to the complications such systems may bring about inclusive of the barrier to patenting for South African SME’s and entrepreneurs, not to mention the lack of capacity to implement such systems/proceedings.

Is there merit in these recommendations made by the DNPIP? Does the document provide any analyses that could guide the reader that the draftsmen of the DNPIP based its recommendations on the models of other countries with similar economies, such as India where recent Patent Law amendments on patentable subject matter was tested in its Courts? Is our patent law, like the President, about to be affected by Indian influences?

In an attempt to answer these questions the specific aspects relevant to the India model are:

  1. TRIPS flexibility provisions
  2. Patent examination and provision for pre- and post-grant oppositions.

TRIPS flexibility provisions

The TRIPS Agreement incorporates certain “flexibilities.” These aim to permit developing and least-developed countries to use TRIPS-compatible norms in a manner that enables them to pursue their own public policies, either in specific fields like access to pharmaceutical products or protection of their biodiversity, or more generally, in establishing macroeconomic, institutional conditions that support economic development.

Member countries can exploit creative solutions to transpose into their national law those concepts that the TRIPS Agreement articulates such as novelty and inventiveness; or of situations of extreme urgency for the purposes of compulsory licenses.

Article 27 (1) of TRIPS defines patentable subject matter. Article 31 of TRIPS enunciates the flexibility of compulsory licensing without defining these requirements clearly.

Although provisions of the TRIPS Agreement permit the grant of compulsory licences to enable generic production of medicines, countries without domestic manufacturing capacity cannot avail themselves of this flexibility. The option of importing generic medicines is hampered by the restriction in the TRIPS Agreement that requires production under compulsory licence to be predominantly for the supply of the domestic market (section 31(f)). This has raised concern that exporting countries may have difficulties exporting sufficient quantities to meet the needs of those countries with insufficient or no manufacturing capacity. Paragraph 6 of the Doha Declaration (of Nov 2001) recognised this problem in that “WTO members with insufficient or no manufacturing capacities in the pharmaceutical sector, could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement” and thus instructed the TRIPS Council to find an expeditious solution to this problem and to report to the General Council before the end of 2002.

On 30 August 2003 the General Council of the WTO adopted the Decision on Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (the August Decision). The WTO solution is essentially a waiver of the export restriction, thereby allowing the total amount of production under a compulsory licence to be exported. The full impact of this depends on the extent to which national laws allow for it, and will require specific changes to national laws of TRIPS Member countries.

The DNPIP states as two of its objectives (item 10 and 13 on page 4):

”10. To improve national compliance with international treaties of which South Africa is a member.”

“13. Introduce a public health perspective into national IP laws and adopt a common and united stand among different government agencies on improving access to medicines.”

Within the document on page 12 this statement and these recommendations are made:

“The WTO administers the TRIPS Agreement, which has patent flexibilities suitable to cure access to public health, in particular by developing countries such as South Africa. Further, the WTO Doha Development Agenda process resolved to allow TRIPS to have further patent flexibilities. South Africa has a massive disease burden, e.g. AIDS, HIV, TB, Hepatitis, Cancer and Heart Diseases. Patent flexibilities can easily alleviate access to medicines.

Recommendations:

– South Africa must change the Patents Act to incorporate patents flexibilities as contained in the TRIPS Agreement after the Doha Decisions.

– The Patents Act should be amended to be amenable to issues related to access to public health.”

The Law in context to the DNPIP

To contextualise the recommendations one has to consider the relevant provisions of the law. As the DNPIP does not identify the specific TRIPS flexibilities that can be used an assessment of the extent to which the South African IP law requires amendment is rather difficult. For the purpose of this paper, let’s assume (from the various references to these aspects throughout the DNPIP) that the flexibilities with respect to Patent Law would be the requirements for patentability and compulsory licensing.

The relevant provisions of the Law

Patentability – South Africa

Addressing the specific aspect with relevance to Indian law (section 3(d) of the Indian (Amendment) Patent Act of 2005), section 25 of the South African Patents Act (Patents Act 57 of 1978 as amended) (The SA Patents Act) is relevant.

The SA Patents Act currently provides in section 25(1) that:

 “A patent may, subject to the provisions of this section, be granted for any new invention which involves an inventive step and which is capable of being used or applied in trade or industry or agriculture.”

It further provides in section 25(9) that:

“In the case of an invention consisting of a substance or composition for use in a method of treatment of the human or animal body by surgery or therapy or of diagnosis practised on the human or animal body, the fact that the substance or composition forms part of the state of the art immediately before the priority date of the invention shall not prevent a patent being granted for the invention if the use of the substance or composition in any such method does not form part of the state of the art at that date.”

As such South African law allows for the patent protection for new use of know substances.

Patentability – India

The Patents (Amendment) Act of 2005 of India (the third of three amendments to the Patents Act of 1970) extends the product patent protection to the areas of pharmaceuticals and agricultural chemicals.

The specific amendment defining non-patentable subject matter of relevance to this paper is section 3(d), which currently reads:

“The mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance or the mere discovery of any new property or new use for a known substance or of the mere use of a known process, machine or apparatus unless such known process results in a new product or employs at least one new reactant.

Explanation – For the purposes of this clause, salts, esters, ethers, polymorphs, metabolites, pure form, particle size, isomers, mixtures of isomers, complexes, combinations and other derivatives of known substance shall be considered to be the same substance, unless they differ significantly in properties with regard to efficacy.”

As the amendment of the Indian Patent law is an attempt to prevent evergreening, and extended monopolies, section 3(d) stipulates that only those pharmaceutical “derivatives” that demonstrate significantly enhanced “efficacy” are patentable. In this regard, section 3(d) draws a vivid distinction between “evergreening” and incremental innovation. By allowing only derivatives with added efficacy to be patentable, section 3(d) encourages further improvement and development of existing technologies that help bring improved products to the market, thereby also addressing public health needs.

The DNPIP recommendations

There is only one reference to amendment of legislation with respect to new use of known products in the DNPIP, which we find in Chapter 2 on page 23. Here it is recommended that:

“South African legislation should allow strict rules to apply to patenting as competition principles may be undermined. This should exclude diagnostic, therapeutic and surgical methods from patentability, including new uses of known products, as is the case under the TRIPS Agreement.”

As the drafter motivates the change with reference to competition principles that are not identified. It is hard to say what particular competition issue. It may be that the recommendation seeks to address “evergreening”. There is no analyses or any reference whatsoever to comparative laws of any country, or even any reference to case law applying the enforcement of these provisions such as the recent case in India.

It is therefore the opinion of the author that it cannot be argued that the Indian legislative changes with respect to non-patentability of new uses for known substances influenced the drafters of the DNPIP.

Compulsory licensing

Compulsory licensing is incorporated into the SA Patents Act in sections 55 (dependent patents) and 56 (abuse of right). (Similar to article 84 of the Indian Patents Act of 1970 as amended).

The DNPIP I Chapter 2 on page 24 recommends that:

“Compulsory licensing should be introduced in South Africa in line with international treaties, such as the Doha Decision 6 of the WTO negotiations on Trade and Public Health”.

There is no specific reference in the DNPIP that models of other countries should be followed.

However, with all due respect, the current South African law needs no amendment with respect to compulsory licensing, it is merely a matter of application and use. With the debate on access to healthcare it is rather strange that South African Courts have not yet granted a compulsory licence for a pharmaceutical-based patent. In addition to the SA Patents Act South Africa has in 1997 introduced section 15C to the Medicines and Related Substances Act 101 of 1965, which in essence addresses the necessary access to medicines (to our knowledge this Act has never been put into operation).

The drafters of the DNPIP do not seem to be aware of this legislation as no mention is made thereof.

Patent search and examination

The South African prosecution system is a deposit based system in which patent applications are only examined as to their formalities. I.e. patent applications are not examined for novelty, inventive step and utility, if a patent application complies with the required formalities, the application can proceed to grant. Thus the risk exists that this system is likely to result in grant of multiple patents on e.g. a single medicine, and to allow evergreening to occur.

In a patent search and examination system the patentability of an invention is assessed by qualified patent examiners who conduct prior art searches to compare the claimed invention to any publications made earlier than the priority date of an application for a patent. A search and/or examination report is then issued. In an examination report the patentability of the claimed invention is discussed in view of the cited prior art. A patent applicant can make certain amendments to the patent claims of the application overcome the prior art citations and objections of the examiner and thereby ensuring that the patent is valid in view of prior art.

In many forms scattered throughout the DNPIP are recommendations that relate to the introduction of a “search and examination” system for patents:

“There is an outcry by users of the patent system that South Africa needs strong patents that can survive the test of competitiveness throughout the world. This can be achieved if a substantive Search and Examination of Patents system is followed.”

“Cabinet should consider approving the establishment of a substantive Search and Examination of Patents to have strong technologies.”

“This also means that South Africa may need to create a Substantive Search and Examination since it is using a depository system that inherently grants weak patents.”

“Cabinet should consider approving the establishment of a Search and Examination Office to have strong technologies.”

Despite the fact that these recommendations contain incorrect factual statements, it is not clear at all whether any particular country’s model was considered, or will be considered. There are statements contained in the DNPIP that South Africa as a developing country should follow “similar economies such as Brazil, India and Egypt are granting fewer patents due to the fact that they use the Substantive Search and Examination of Patents. India, in particular, has a pre-opposition and post-grant opposition.”

Later on in the DNPIP this statement is made:

“As mentioned earlier, South Africa uses a registration system that is not per se able to scientifically critique “newness”, “obviousness”, “novelty” and “usefulness in trade or agriculture”. Due to this, weaker patents are granted. Coupled with the fact that the South African Patent Act does not have “pre-opposition” and “post-opposition” procedures as described earlier, the registration is allowing “weaker” patents that are pliable to frustrate access to public health. Similar economies such as Brazil, India and Egypt are granting fewer patents due to the fact that they use the Substantive Search and Examination of Patents. India, in particular, has a pre-opposition and post-grant opposition.”

No supporting data of the referenced countries are provided to allow any conclusions as to whether a particular country’s system for search and examination will be followed.

Pre-and Post-grant oppositions

Pre-grant opposition proceedings allows a third party to oppose the grant of a patent during the prosecution of an application after the publication of the application. The requirements and regulations for this form of proceedings differ from jurisdiction to jurisdiction.

A post grant opposition is a second opportunity for third parties to oppose the validity of a patent after grant thereof.

The DNPIP seems to confuse the pre- and post-grant opposition proceedings with the search and examination proceedings of a patent (as is clear from the citation in the paragraph on search and examination above).

Search and Examination is focussed on the prosecution of the application between applicant and examining office, whereas pre-and post-grant oppositions concerns interference by third parties. Although before a patent tribunal as opposed to a court, it is not formally part of the prosecution of the patent.

We believe the intent of the DNPIP to mention the opposition proceedings in compliment to search and examination as the DNPIP includes a specific section on Pre- and Post-Opposition of Patents. Unfortunately this is not clear from the document.

Despite this misunderstanding, is there any reference to other countries systems for pre-and post-grant oppositions on which the recommended system for South African IP law could be built?

The DNPIP in this context makes reference to similar economies that should be considered:

“A country like India resorted to pre- and post-grant opposition to facilitate a possibility of opposing weaker patents as described above. The South Africa Patents does not prescribe for such. This procedure has been a success to challenge “weaker” patents or patents that do not meet the requirements of “newness”, “novelty”, “obviousness” and “usefulness for trade/agriculture”.

“The purpose of the opposition proceedings to provide a more affordable forum to have patents invalidated that do not meet the “newness”, “novelty”, “obviousness” and “usefulness for trade/agriculture“.

 “A cost and benefit analysis should be conducted through the Regulatory Impact Assessment (RIA) process and benchmarks should be based on similar economies such as India, Brazil and Egypt.”

Unfortunately the DNPIP does not contain any empirical data regarding any potential investigation on the cost, lack of institutional capacity (which was the reason why opposition proceedings were removed from the 1952 Act when the 1978 Act was adopted) or any foreign comparative analyses into regimes such as India.

It can thus be concluded that the DNPIP was not per se influenced by the Indian pre- and post-grant opposition proceedings, other than recognising that these do exist and may potentially be an example South Africa may consider.

Dr MM Kleyn

Fellow of the Chair of Intellectual Property Law

Posted in IPStell, Patents Tagged DNPIP, Draft National Policy, India, patent, Reform

INTRODUCTION

Have you ever basked in the warm sunshine of a glorious summer’s day, in daydreaming mode, and allowed your mind simply to wander at random? You start with a thought, you turn it over in your mind, and then a point is reached where you go off at a tangent and muse over some largely unrelated thought, only to be diverted in yet another direction. Eventually you may go the full circle and come back momentarily to the point of departure, before heading off again elsewhere. Daydreaming can be a very pleasant experience and it has the beauty that you do not have to make any decisions or reach any conclusions. Your mind is free to roam at will.

The Department of Trade and Industry has issued a document entitled “Draft National Policy on Intellectual Property, 2013” (“DNPIP”) in General Notice No.918 of 2013, published in the Government Gazette of 4 September 2013 (full text here PDF_Icon). In this notice an invitation has been extended for the public to comment on the DNPIP. To do so, of course, requires the document to be studied. Ay, there’s the rub! Reading the DNPIP calls to mind daydreaming as the document creates the impression that it is a record of someone’s languid reverie.

This Chair of Intellectual Property Law (CIP) has heeded to the call to comment and it has submitted a comprehensive brief to the DTI.  The CIP’s comments consist of a suite of separate, but related, complementary documents comprising the following:

1.   An overview of the DNPIP, as a whole, prepared by Professor OH Dean, Chair of IP Law.

2.   A commentary on those aspects of the DNPIP dealing primarily with copyright, trade marks and related issues prepared by Professor OH Dean.

3.   A commentary on primarily patents, design and technology transfer matters prepared by Dr M Kleyn, a Fellow of the CIP.

4.   A commentary dealing primarily with matters pertaining to the internet prepared by Mr C Jooste, a Fellow of the CIP.

5.   A commentary dealing primarily with computer programmes prepared by Dr S Karjiker, a Fellow of the CIP.

 The brief can be accessed here PDF_Icon. The views expressed in the brief have much in common with comments submitted to the DTI by Judge/Professor Louis Harms. His comments can be accessed here PDF_Icon.  The CIP is thus in good company in its estimation of the DNPIP. Not to be outdone, the Vine Oracle has seized this opportunity to offer its own ten cents worth.

A LONG AND WINDING ROAD

The layout and presentation of the DNPIP makes a discussion of it a difficult chore.  This is so because, with respect, its layout and presentation have shortcomings which are not conducive to a systematic and consequential analysis of it. The document’s language and syntax, as well as its classification of subject matter, are often confusing with the result that it is difficult to comprehend what the author is saying.  It has indeed been described as “an incoherent stream of consciousness”.

The document has sections of its initial portion dealing with “objectives” and “background-problem statement”.  The stated objectives are perfectly laudable but are not comprehensive for purposes of a policy document.  For instance, the section is silent on the issues of joining and implementing the provisions of International Intellectual Property Agreements, and most importantly, taking steps to ensure that our Intellectual Property Legislation stays up to date and relevant in a rapidly evolving intellectual property environment..

The purported problem statement lists a series of characteristics with which it is apparently suggested that the current situation in South Africa complies.  When this list is weighed up against the objectives of the policy, one cannot help but asking: “what is the problem?” because it seems as though the stated objectives are already met.

The document provides discussion in various chapters, which overlap somewhat, and which collectively do not provide comprehensive coverage of the field of intellectual property. It is difficult to ascertain what the document in its entirety has to say on any particular topic.

UNPACKING THE MISSIVE

The document purports to be an exposition of the Government’s policy on Intellectual Property.  Outwardly, it has the appearance of a policy document consisting of a number of issues on which there is a discourse, followed by statements labelled as “recommendations”. However, the discourses are frequently renditions of the subjective views of the author on wide ranging and disparate issues of intellectual property without giving rise to any meaningful resolutions as to what stances should be adopted or action should be taken by the Government.  The range of subjects covered by the document is by no means comprehensive or exhaustive of pertinent issues pertaining to intellectual property and one is left wondering why certain important issues have been omitted from the review.  For instance, the document is completely silent on anything to do with the Performer’s Protection Act, the Registration of Copyright in Cinematograph Films Act, the Counterfeit Goods Act and counterfeiting in general, and the Intellectual Property Rights from Publicly Financed Research and Development Act (the author seems to be unaware of the existence of this latter Act).

Is one to assume that the Government has no policy on these matters or that they do not rank as sufficiently important to be covered by a statement of policy?  On the other hand, the document makes reference to the Heraldry Act and suggests that it is part of the general body of law dealing with intellectual property.  Nowhere in the world, that the Vine Oracle is aware of, is heraldry considered to be a species of Intellectual Property Law.

The document has a few basic themes about which it pontificates (sometimes hollowly).  These include the imbalance between the strengths of the positions of developed countries and developing countries (into which group it is considered that South Africa falls); the fact that there should be co-operation and co-ordination between the various government departments and entities that are seized with various aspects of intellectual property, such as the Department of Trade and Industry, the Department of Science and Technology, the Department of Communications and others (it is doubtful whether any of these have been consulted on the contents of the DNPIP); the fact that developed countries attempt to impose obligations on developing countries over and above those imposed by the various international treaties in the field and that, on the contrary, there is rather a need to limit the restrictions on free activity imposed by the Intellectual Property Treaties; Patent Law, and especially the non-examination of South African patent applications is a direct cause of excessive costs of medicines; Intellectual Property laws are anti-competitive and our law provides little redress for this situation.  Regrettably, the discourses on these issues, while perhaps being pertinent issues appropriate for being addressed, give rise to very little if any concrete and positive proposals as to what the way forward should be.

There are instances where the document focuses on issues and discusses them critically, despite it being stated unequivocally, and correctly, that these issues are not, or are no longer, pertinent in contemporary intellectual property. What is the point?

The document is littered with purported “recommendations”. As a general pattern, these recommendations follow on after a discourse on a particular subject.  There are some recommendations which are reasoned and which flow from the preceding discourse.  On the other hand, there are recommendations which are not preceded by any discourse and are thus unmotivated. In some instances, recommendations are self-evident, trite or are platitudes. Some are absurd. As a general proposition, the recommendations lack particularity and do not specify concrete steps or procedures to give rise to their practical implementation.  On the whole, they amount to little more than vague expressions of intent or hope.

In general, the document displays an alarming lack of understanding or knowledge of existing IP law and several of the discourses and recommendations flowing from them are tainted and undermined by this factor.

OPPORTUNITY TO COMMENT?  COGENT EVIDENCE OF THE NEED TO REDRAFT!

The DNPIP has been made available for comment by the public and it is therefore presumably intended to be capable of being understood by the general public.  For a number of reasons, not in the least its tortuous presentation and expression, it will be largely incomprehensible to the general public. Their ability to comment meaningfully on it is therefore seriously limited.  Part of the reason why the document will be incomprehensible to the general public is that it makes use of terminology (without appropriate explanations) which is foreign to them. Try this one for size: “many BITS deal with IP issues and introduce TRIPS – PLUS, TRIMS – PLUS and SCM – Plus in many respects”. Indeed, this statement is barely comprehensible to the cognoscenti! Never mind the general public having difficulty in understanding the policy document, it is difficult to see how members of government, who ultimately will be seized with the adoption or otherwise of the policy, will be able to comprehend it and be able to evaluate its worth, or lack thereof.

In the final analysis, the DNPIP is unsatisfactory and it requires to be redrafted so as to make it a comprehensive policy document, dealing with all aspects of intellectual property law, which is rational, well-motivated and comprehensible to the uninitiated.  It is recommended that the present document should be regarded as no more than a first tentative attempt to highlight some (but by no means all) of the issues which may possibly have to be addressed in formulating a policy on intellectual property.  Once the DTI has collected its thoughts properly on the issue of IP policy, professional consultants, skilled in intellectual property and in drafting documents such as policy reviews, should be commissioned to prepare an appropriate document.  In this manner the process of adopting a policy on intellectual property can be taken forward in a rational, practical and effective manner. However, the DTI is to be commended for trying!

Office of the Chair of Intellectual Property

Stellenbosch University

Posted in Copyright, Design, IPStell, Patents, Publications, Trade Marks, Traditional Knowledge Tagged Copyright, design, DTI, intellectual property, intellectual property policy, IP Policy, National IP Policy, patent, SA IP Policy, TK, trademark, traditional knowledge
  • « Older Entries
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 19
  • Newer Entries »
Study IP Law

Keywords

Advertising Bill brand case comments Copyright copyright amendment bill culture disaster DTI enforcement expropriation Government indigenous infringement intellectual property IP IP Public Lecture Knowledge law legislation Lion Sleeps Tonight Litigation Mbube mistake Owen Dean Parliament patent Plagiarism plain packaging problem protection regulation review rights Solomon Linda sport TK tobacco trade mark trademark trademarks Traditional traditional knowledge world ip day

NOTICE

The views and opinions expressed on the CIP website are strictly those of the page author(s) and content contributor(s). The contents of the CIP website have not been reviewed or approved by Stellenbosch University.

© 2025 CIP – The Anton Mostert Chair of Intellectual Property, Stellenbosch University All Rights Reserved

Terms & Conditions
Avatars by Sterling Adventures

Latest Posts

  • IP Public Lecture 2024 – Player IP: Show Me the Money!
  • Sports Law Conference 2024
  • IP Public Lecture 2023 – Gin and Tonic Anyone? Similar or Not?
  • Rationale of copyright exceptions*
  • Written submissions on Copyright Amendment Bill and Performers’ Protection Amendment Bill

The Anton Mostert Chair of Intellectual Property is an independent research unit of the Faculty of Law, Stellenbosch University. For more information visit the About page, or contact us: ipchair@sun.ac.za

Notice

The views and opinions expressed on the CIP website are strictly those of the page author(s) and content contributor(s). The contents of the CIP website have not been reviewed or approved by Stellenbosch University.

© 2025 CIP - The Anton Mostert Chair of Intellectual Property, Stellenbosch University All Rights Reserved

WordPress Theme Custom Community 2 developed by Macho Themes